Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood molecules and cognitive symptoms.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer’s disease in older adults.

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...

Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Here, we look at some words and questions to try to avoid when talking to a person with dementia. ... With announcements on new Alzheimer's drugs, the launch of essential care research partnerships, ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes Diagnosis Linked to Dementia Risk Nov. 19, 2024 ...

Scientists are looking at how DNA differences could protect people from dementia – and how this can help others ...

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...